Technical Analysis for NTEC - Intec Pharma Ltd.

Grade Last Price % Change Price Change
F 9.63 -14.93% -1.69
NTEC closed down 14.93 percent on Tuesday, August 3, 2021, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical NTEC trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -14.93%
Calm After Storm Range Contraction -14.93%
Wide Bands Range Expansion -14.93%
Fell Below 20 DMA Bearish -14.70%
Calm After Storm Range Contraction -14.70%
Inside Day Range Contraction -14.70%
Wide Bands Range Expansion -14.70%
Oversold Stochastic Weakness -14.70%
Older End-of-Day Signals for NTEC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Intec Pharma Ltd., a drug development company, develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill, in Israel. The Accordion Pill, a novel gastro-retentive delivery system improves the pharmacokinetics and pharmacodynamics of various drugs. The company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson's disease patients. Its pipeline also comprises The Accordion Pill – Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Intec Pharma Ltd. is based in Jerusalem, Israel.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Development Drugs Drug Development Parkinson's Disease Pharmacokinetics Pharmacodynamics Carbidopa L Dopa Catecholamines

Is NTEC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 36.8
52 Week Low 8.8
Average Volume 1,095,348
200-Day Moving Average 15.96
50-Day Moving Average 14.09
20-Day Moving Average 12.39
10-Day Moving Average 11.72
Average True Range 2.05
ADX 35.97
+DI 44.57
-DI 18.74
Chandelier Exit (Long, 3 ATRs) 11.64
Chandelier Exit (Short, 3 ATRs) 15.02
Upper Bollinger Bands 15.72
Lower Bollinger Band 9.06
Percent B (%b) 0.09
BandWidth 53.82
MACD Line -0.99
MACD Signal Line -0.80
MACD Histogram -0.1875
Fundamentals Value
Market Cap 38.02 Million
Num Shares 3.95 Million
EPS -1.28
Price-to-Earnings (P/E) Ratio -7.55
Price-to-Sales 0.00
Price-to-Book 0.71
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.89
Resistance 3 (R3) 12.13 11.61 11.51
Resistance 2 (R2) 11.61 11.04 11.49 11.39
Resistance 1 (R1) 10.62 10.68 10.36 10.38 11.26
Pivot Point 10.11 10.11 9.98 9.99 10.11
Support 1 (S1) 9.11 9.53 8.86 8.88 8.00
Support 2 (S2) 8.60 9.17 8.48 7.87
Support 3 (S3) 7.61 8.60 7.75
Support 4 (S4) 7.37